by Mette Bach Dyremose | Mar 11, 2026 | News
ReproUnion has published a new collaboration case highlighting how the Swedish company Spermosens has clinically validated its functional male fertility diagnostic, JUNO-Checked, at the Reproductive Medicine Center (RMC) in Malmö. The case documents how facilitated...
by Mette Bach Dyremose | Feb 26, 2026 | News
The RUBIC Seminar on 23 February marked an important milestone for the ReproUnion Biobank & Infertility Cohort. What began as an ambitious cross-border research infrastructure is now delivering concrete scientific results – based on biological samples and detailed...
by Mette Bach Dyremose | Feb 16, 2026 | News
ReproUnion is proud to contribute to Sweden’s national inquiry Framtid med Barn (A Future with Children), which is a comprehensive initiative addressing the societal, economic and demographic implications of declining birth rates in Sweden. As part of a dedicated...
by Mette Bach Dyremose | Dec 10, 2025 | News
On December 4th, ReproUnion held a matchmaking and co-creation event at Medeon Science Park in Malmö, which brought together startups, clinicians, researchers, and industry. The aim was to explore how collaboration and testbed frameworks can help accelerate innovation...
by Mette Bach Dyremose | Dec 9, 2025 | Spotlight Interview
This summer Rita Lobo joined ReproUnion’s Executive Board as Ferring Pharmaceutical’s representative, and we have taken the opportunity to ask her a few questions about her background and first impressions and activities in ReproUnion. What is your background in...
